Drug intelligence / Profile preview

paracetamol + naproxen

Development stage
Unknown
Lead developer
Kenvue
Modality
Small Molecules
Administration
Oral
01

Overview

Paracetamol + naproxen is a fixed-dose combination analgesic and anti-inflammatory medication. It combines paracetamol (acetaminophen), a non-opioid analgesic and antipyretic that primarily acts on the central nervous system, with naproxen, a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis. This combination is intended to provide enhanced pain relief compared to either agent alone by utilizing complementary mechanisms of action. Haleon is developing an immediate-release tablet formulation (MFC-06285) for the treatment of pain and inflammation, currently undergoing pharmacokinetic and bioavailability studies to evaluate its performance relative to monotherapy comparators and the effect of food on absorption.

Other names
acetaminophen + naproxen
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)COX-1 (Prostaglandin G/H synthase 1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + naproxen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + naproxen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call